Browsing by Author Sasadeusz, J

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2015Adoptive T cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipientBlyth, Emily; Gottlieb, David; Micklethwaite, Kenneth; Withers, Barbara Phyllis; Clancy, Leighton; Fleming, S; Hughes, P; Langsford, D; Macesic, N; Majumdar, S; Nicholls, K; Sasadeusz, J; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Adoptive T cell immunotherapy for treatment of ganciclovir-resistant cytomegalovirus disease in a renal transplant recipient, American Journal Of Transplantation, vol.15, 3, 2015,pp 827-832
2009Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis CHaber, Paul; McCaughan, Geoffrey William; Baker, D; Dore, Gregory J.; Hellard, Margaret; Kaldor, J; Lloyd, Andrew; Marks, P; Matthews, G; Rawlinson, William; Sasadeusz, J; White, Peter A; Yeung, B; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteCharacteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C, Clinical Infectious Diseases, vol.48, 5, 2009,pp 650-658
2011Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapyWeltman, Martin; Barton, David; Dore, Gregory J.; Kronborg, Ian J.; Sasadeusz, J; Yoshihara, Motoko; Nepean Clinical School: MedicineClinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy, Addiction, vol.106, 5, 2011,pp 977-984
2012Hepatitis C treatment outcomes in Australian clinicsGeorge, Jacob; Haber, Paul; Amin, Janaki; Dore, Gregory; Gidding, Heather F.; Law, Matthew; Macdonald, Graeme A; Ostapowicz, George; Sasadeusz, J; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Addiction MedicineHepatitis C treatment outcomes in Australian clinics, Medical Journal of Australia, vol.196, 10, 2012,pp 633-637
2011Predictors of deferral of treatment for hepatitis C infection in Australian clinicsGeorge, Jacob; Strasser, Simone; Amin, Janaki; Dore, Gregory J.; Gidding, Heather F.; Jones, Tracey; Law, Matthew G.; Macdonald, Graeme A; Sasadeusz, J; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicinePredictors of deferral of treatment for hepatitis C infection in Australian clinics, Medical Journal of Australia, vol.194, 8, 2011,pp 398-402
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434